RT @deoanzai: 乳がんでタモキシフェン治療を受けている女性にDIM(ジインドリルメタン)またはプラセボを12ヶ月投与。 DIM群はエストロゲンの代謝が善玉のほうに誘導され、SHBG(性ホルモン結合タンパク)も増えた。 https://t.co/tU4icMp3lJ
RT @DCGreenZone: "Further research is warranted" No dude, the people will do the research, you can go fishing. https://t.co/kJflBzqRrq http…
RT @deoanzai: 乳がんでタモキシフェン治療を受けている女性にDIM(ジインドリルメタン)またはプラセボを12ヶ月投与。 DIM群はエストロゲンの代謝が善玉のほうに誘導され、SHBG(性ホルモン結合タンパク)も増えた。 https://t.co/tU4icMp3lJ
乳がんでタモキシフェン治療を受けている女性にDIM(ジインドリルメタン)またはプラセボを12ヶ月投与。 DIM群はエストロゲンの代謝が善玉のほうに誘導され、SHBG(性ホルモン結合タンパク)も増えた。 https://t.co/tU4icMp3lJ
Found a RCT: results seemed promising but there’s a lack of research. “In patients taking tamoxifen for breast cancer, daily DIM promoted favorable changes in estrogen metabolism and circulating levels of SHBG.” https://t.co/XTFUaxZdEK
In patients taking tamoxifen for breast cancer, daily BR-DIM promoted favorable changes in estrogen metabolism and circulating levels of SHBG. Further research is warranted to determine whether BR-DIM associated decreases in... https://t.co/u1V3MnCSfq
A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen https://t.co/hCP8WTCZCX
A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen. https://t.co/iBanMQwXXw
@WickloDietitian @Brad_Dieter So just peeped in Pubmed for indole-3-carbinol (from brassicas as you know) ...here's your RCT https://t.co/fy31kWLk2g .